Polycystic ovarian syndrome (PCOS) is a relatively common endocrine disorder, afflicting between 6% and 13% of women globally.
While PCOS has been around for nearly 100 years, the way researchers and physicians are talking about this disorder is evolving. And it’s high time.
In particular, a growing number of experts believe the name “polycystic ovarian syndrome” doesn’t fit the condition adequately.
And that matters…because the mismatch between PCOS’s name and what it actually is has had real consequences for how women are diagnosed and treated for this condition.
Why the Name Is Changing
The term “polycystic ovarian syndrome” puts almost all of the attention and emphasis on a woman’s ovaries. Specifically, on the presence of ovarian cysts that can be detected via ultrasound.
The problem? Not all women with PCOS have visible cysts. And even for those who do, the cysts aren’t really the point. The reality is that even when cysts are detected, they’re the downstream effect of a much more systemic process—one that involves hormone imbalances, insulin resistance, chronic inflammation, and metabolic dysfunction.
As a consequence, you may start hearing the term PMOS—polyendocrine metabolic ovarian syndrome—used in lieu of PCOS. The updated name reflects what researchers and clinicians are increasingly recognizing about this condition:
That it is fundamentally metabolic in nature, not just reproductive.
What PMOS Involves
When you reframe this condition through a metabolic lens, the picture becomes clearer.
At its core, PMOS involves a cycle of disruptions that reinforce one another.
Insulin resistance causes elevated insulin levels. Elevated insulin signals the ovaries to produce excess androgens (like testosterone). Those elevated androgens disrupt ovulation. Disrupted ovulation means less progesterone production. Less progesterone relative to estrogen creates further hormone imbalance in the form of estrogen dominance.
And chronic low-grade inflammation runs through all of the above, driving each individual component and making the cycle hard to break.
As for the ovarian cysts that have gotten more attention than they deserve to this point? They form when ovarian follicles that should have matured and released an egg don’t complete that process. Again, this is a consequence of the disrupted hormonal signaling described above—not the cause of it.
Beyond Irregular Cycles
One reason the PCOS label has failed so many women is that it leads both patients and physicians to focus primarily on menstrual irregularity and fertility, when the symptomology is actually far broader than that. The result has been a disconnect between what women experience by way of symptoms, and what has been considered a more “textbook” presentation.
Women with PMOS may experience any of the following:
- Persistent fatigue
- Difficulty losing weight, particularly around the abdomen
- Brain fog
- Mood swings, anxiety, or depression
- Acne, particularly along the jawline and chin
- Thinning hair on the scalp and/or excess hair elsewhere
- Blood sugar fluctuations
- Intense carbohydrate cravings
While these symptoms may seem unrelated at first glance, they aren’t. They’re indicative of the insulin resistance, androgen excess, and hormonal disruption that sit right at the center of this condition.
It Doesn’t End at Menopause
Another important misconception is that because PMOS involves the ovaries and menstrual cycles, it must resolve once women reach menopause.
Unfortunately, it doesn’t work that way.
The metabolic aspects of PMOS—insulin resistance, inflammation, cardiovascular risk, and the tendency toward hormone imbalance—persist well beyond the reproductive years. In some respects, the transition to menopause can intensify these issues, as the protective effects of estrogen on insulin sensitivity and inflammation begin to diminish.
With that being the case, women with PMOS who are approaching perimenopause or menopause deserve care that addresses both the transition itself, as well as the metabolic undercurrents caused by this condition.
Why This Renaming Matters
Changing a name might seem like a minor semantic distinction. But in medicine, how a condition is named shapes how it is understood, diagnosed, and treated.
In particular, a woman with no visible ovarian cysts might slip through the diagnostic cracks and be sent home without treatment (or answers). And a woman whose symptoms are primarily metabolic (rather than reproductive) may never be evaluated for this condition at all. Or…a woman who was diagnosed with PCOS many years ago and treated with birth control (to address irregular periods) may not know that her underlying insulin resistance and inflammation were never addressed.
The shift away from PCOS and toward PMOS is an invitation for physicians and patients to take a broader view—to look at the hormonal, metabolic, and inflammatory picture as a whole, rather than focusing narrowly on the ovaries.
Getting the Right Answers
If any of this resonates—whether you’ve carried a PCOS diagnosis for years or have simply been struggling with symptoms that haven’t been successfully explained or treated—it may be time for a more comprehensive evaluation.
At Renew Youth, we understand that hormone health is rarely simple. We pride ourselves on taking the kind of individualized approach that complex conditions like PMOS require. Call us at (800) 859-7511 or use our easy contact form to schedule your complimentary 30-minute consultation.